PL3368527T3 - Tosylan palbocyklibu - Google Patents
Tosylan palbocyklibuInfo
- Publication number
- PL3368527T3 PL3368527T3 PL16859141T PL16859141T PL3368527T3 PL 3368527 T3 PL3368527 T3 PL 3368527T3 PL 16859141 T PL16859141 T PL 16859141T PL 16859141 T PL16859141 T PL 16859141T PL 3368527 T3 PL3368527 T3 PL 3368527T3
- Authority
- PL
- Poland
- Prior art keywords
- palbociclib
- tosylate
- palbociclib tosylate
- Prior art date
Links
- AHJRHEGDXFFMBM-UHFFFAOYSA-N palbociclib Chemical compound N1=C2N(C3CCCC3)C(=O)C(C(=O)C)=C(C)C2=CN=C1NC(N=C1)=CC=C1N1CCNCC1 AHJRHEGDXFFMBM-UHFFFAOYSA-N 0.000 title 1
- 229960004390 palbociclib Drugs 0.000 title 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU1500506A HU230962B1 (hu) | 2015-10-28 | 2015-10-28 | Palbociclib sók |
| PCT/HU2016/050050 WO2017072543A1 (en) | 2015-10-28 | 2016-10-26 | Palbociclib salts |
| EP16859141.0A EP3368527B1 (en) | 2015-10-28 | 2016-10-26 | Palbociclib tosylate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3368527T3 true PL3368527T3 (pl) | 2021-11-02 |
Family
ID=89991966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16859141T PL3368527T3 (pl) | 2015-10-28 | 2016-10-26 | Tosylan palbocyklibu |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP3368527B1 (pl) |
| EA (1) | EA035346B1 (pl) |
| ES (1) | ES2875402T3 (pl) |
| HU (2) | HU230962B1 (pl) |
| LT (1) | LT3368527T (pl) |
| PL (1) | PL3368527T3 (pl) |
| UA (1) | UA123218C2 (pl) |
| WO (1) | WO2017072543A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109575021B (zh) * | 2019-01-22 | 2020-09-18 | 北京海美桐医药科技有限公司 | 一种哌柏西利的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ534069A (en) | 2002-01-22 | 2007-03-30 | Warner Lambert Co | 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones to be used to treat neurodegenerative disorders, viruses and cancer |
| DE602004017474D1 (de) * | 2003-07-11 | 2008-12-11 | Warner Lambert Co | Isethionat salz eines selektiven cdk4 inhibitors |
| EA010691B1 (ru) * | 2004-03-12 | 2008-10-30 | Эгиш Дьёдьсердьяр Нирт. | Комбинация дерамциклана и опиоидов в качестве обезболивающего средства |
| DK3431475T3 (da) | 2013-02-21 | 2021-05-25 | Pfizer | Faste former af en selektiv CDK4/6-hæmmer |
| WO2016024249A1 (en) * | 2014-08-14 | 2016-02-18 | Sun Pharmaceutical Industries Limited | Crystalline forms of palbociclib |
| CN104327078A (zh) * | 2014-10-24 | 2015-02-04 | 上海博氏医药科技有限公司 | Cdk-4/6抑制剂的新合成方法 |
| WO2016066420A1 (en) * | 2014-10-29 | 2016-05-06 | Sandoz Ag | Crystalline forms of palbociclib monohydrochloride |
| WO2016091221A1 (zh) * | 2014-12-12 | 2016-06-16 | 苏州晶云药物科技有限公司 | 吡咯并[2,3-d]嘧啶化合物的盐及盐的新晶型 |
| CZ201589A3 (cs) * | 2015-02-11 | 2016-08-24 | Zentiva, K.S. | Pevné formy soli Palbociclibu |
-
2015
- 2015-10-28 HU HU1500506A patent/HU230962B1/hu unknown
-
2016
- 2016-10-26 EP EP16859141.0A patent/EP3368527B1/en active Active
- 2016-10-26 ES ES16859141T patent/ES2875402T3/es active Active
- 2016-10-26 EA EA201890963A patent/EA035346B1/ru unknown
- 2016-10-26 UA UAA201805312A patent/UA123218C2/uk unknown
- 2016-10-26 LT LTEP16859141.0T patent/LT3368527T/lt unknown
- 2016-10-26 PL PL16859141T patent/PL3368527T3/pl unknown
- 2016-10-26 HU HUE16859141A patent/HUE054908T2/hu unknown
- 2016-10-26 WO PCT/HU2016/050050 patent/WO2017072543A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ES2875402T3 (es) | 2021-11-10 |
| HU230962B1 (hu) | 2019-06-28 |
| LT3368527T (lt) | 2021-08-10 |
| HUE054908T2 (hu) | 2021-10-28 |
| EA035346B1 (ru) | 2020-05-29 |
| WO2017072543A1 (en) | 2017-05-04 |
| EA201890963A1 (ru) | 2018-09-28 |
| EP3368527A1 (en) | 2018-09-05 |
| HUP1500506A2 (en) | 2017-07-28 |
| EP3368527B1 (en) | 2021-04-28 |
| UA123218C2 (uk) | 2021-03-03 |
| EP3368527A4 (en) | 2019-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3389557T3 (en) | Transseptalt leveringssystem | |
| DK3320033T3 (en) | Polyethylenterephthalat-depolymerisering | |
| DK3256579T5 (en) | Cysteinprotease | |
| DK3256580T3 (en) | Cysteinprotease | |
| DK3298030T3 (en) | Anti-cancerfusionspolypeptid | |
| DK3373882T3 (en) | Patientisolator | |
| GB201500806D0 (en) | Aerosol-gnerating aticle | |
| DK3284069T3 (en) | Pos-terminal | |
| DK3336185T3 (en) | Antistof | |
| DK3272750T3 (en) | Morphinan-derivat | |
| DK3380145T3 (en) | Injektionsapparat | |
| DK3324768T3 (en) | Tørdragt | |
| AU361999S (en) | Ballustrade | |
| DK3133099T3 (en) | Polymermodificeret polyoldispersion | |
| DK3242882T3 (en) | Cgrp-antagonistpeptider | |
| DK3294653T3 (en) | Justerbar inline-port | |
| DK3282866T3 (en) | Proteinfibre | |
| LT3368527T (lt) | Palbociklibo tozilatas | |
| AU5516P (en) | LEP08 Lepidosperma squamatum | |
| AU366552S (en) | Nutblock | |
| AU367131S (en) | USB-charger | |
| AU365008S (en) | Playsuit | |
| AU2015165V (en) | PWBC12 Chamelaucium uncinatum | |
| AU362754S (en) | Playsuit | |
| AU2015211V (en) | SGIBL01-0 Scabiosa columbaria |